Skip to main content
. 2016 Apr 5;129(7):763–770. doi: 10.4103/0366-6999.178968

Table 1.

Baseline clinical and procedural characteristics

Variables PCI (n = 465) CABG (n = 457) P
Age, mean (range), years 62 (54–70) 64 (57–70) 0.052
Male, n (%) 367 (78.9) 377 (82.5) 0.170
Diabetes mellitus, n (%) 143 (30.8) 131 (28.7) 0.488
Smoking history, n (%) 230 (49.5) 205 (44.9) 0.161
Hypertension, n (%) 286 (61.5) 269 (58.9) 0.412
Family history, n (%) 41 (8.8) 33 (7.2) 0.372
Dyslipidemia, n (%) 231 (49.7) 158 (34.6) <0.001
Prior stroke, n (%) 45 (9.7) 42 (9.2) 0.800
Prior myocardial infarction, n (%) 66 (14.2) 99 (21.7) 0.003
Prior PVD, n (%) 24 (5.2) 34 (7.4) 0.154
Prior PCI, n (%) 68 (14.6) 31 (6.8) <0.001
EuroSCORE, mean (range) 5 (3–6) 5 (3–6) 0.290
LVEF, mean (range), % 64 (59–70) 62 (54–68) <0.001
Serum creatinine, mean (range), μmol/L 79.6 (70.0–93.7) 84.0 (70.7–97.2) 0.012
Indications for revascularization, n (%)
 NSTEMI 19 (4.1) 16 (3.5) 0.001
 STEMI 55 (11.8) 41 (9.0)
 Stable angina 52 (11.2) 80 (17.5)
 Unstable angina 323 (69.5) 318 (69.6)
 Silent ischemia 16 (3.4) 2 (0.4)
Involved location, n (%)
 Ostium 98 (21.1) 59 (12.9) 0.004
 Body 51 (11.0) 51 (11.2)
 Distal bifurcation 316 (68.0) 347 (75.9)
Extent of diseased vessel, n (%)
 LM only 31 (6.7) 12 (2.6) <0.001
 LM plus single-vessel disease 96 (20.6) 33 (7.2)
 LM plus double-vessel disease 174 (37.4) 105 (23.0)
 LM plus triple-vessel disease 164 (35.3) 307 (67.2)
Chronic total occlusion, n (%) 75 (16.1) 184 (40.3) <0.001
Complete revascularization, n (%) 298 (64.1) 320 (70.0) 0.055
Number of stents (range) 2 (1–4)
 Off-pump CABG 422 (92.3)
 Vessel bypassed 3 (3–3)
 Left internal thoracic use, n (%) 390 (85.3)

PCI: Percutaneous coronary intervention; CABG: Coronary artery bypass grafting; PVD: Peripheral vascular disease; LVEF: Left ventricular ejection fraction; NSTEMI: Non-ST-elevation myocardial infarction; STEMI: ST-elevation myocardial infarction; LM: Left main. EuroSCORE: European System for Cardiac Operative Risk Evaluation. Complete revascularization: All lesions occupying >50% diameter of a segment with a reference diameter of ≥1.50 mm were treated.